Topical Voltaren in Otitis Externa

Phase 2TerminatedNCT00523120

Sieff Medical Center20 enrolled

Overview

Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.

anticipated advantages are: reduction of inflammation and edema, no fungal overpopulation- when steroids are employed, contains boric acid as an ingredient, high safety profile, can be switched to antibiotic therapy later, can be used in conjunction wit steroids

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Otitis Externa

Interventions

diclofenac sodiumDRUG

topical solution used in ear 5 drops 8 3/day

dexotcDRUG

aural drops

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Adults having otitis externa as single diagnosis mild to moderate Exclusion Criteria: * Diabetes * Children * Pregnant women * Immune compromise * Starting other treatment * Moderate to severe otitis externa

Locations (1)

Sieff Medical Center

Safed, Israel

Outcomes

Primary Outcomes

reducing oral analagestic use

Time frame: 1 week

Secondary Outcomes

adding an alternative treatment for otitis externa

Time frame: 1 week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.